Leuconostoc Citreum Inhibits Adipogenesis and Lipogenesis by Inhibiting p38 MAPK/Erk 44/42 and Stimulating AMPKα Signaling Pathways
International Journal of Molecular Sciences · 17.04.2023 · 24 (8) · 7367
DOI: 10.3390/ijms24087367 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.04.2023. Verfasst von Hyo-Shim Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Sunchon University, Suncheon 57922, Republic of Korea. Hauptthemen laut MEDLINE: Adipogenesis, Lipogenesis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Probiotics provide a range of health benefits. Several studies have shown that using probiotics in obesity treatment can reduce bodyweight. However, such treatments are still restricted. Leuconostoc citreum, an epiphytic bacterium, is widely used in a variety of biological applications. However, few studies have investigated the role of Leuconostoc spp. in adipocyte differentiation and its molecular mechanisms. Therefore, the objective of this study was to determine the effects of cell-free metabolites of L. citreum (LSC) on adipogenesis, lipogenesis, and lipolysis in 3T3-L1 adipocytes. The results showed that LSC treatment reduced the accumulation of lipid droplets and expression levels of CCAAT/ enhancer-binding protein-α & β (C/EBP-α & β), peroxisome proliferator-activated receptor-γ (PPAR-γ), serum regulatory binding protein-1c (SREBP-1c), adipocyte fatty acid binding protein (aP2), fatty acid synthase (FAS), acetyl CoA carboxylase (ACC), resistin, pp38MAPK, and pErk 44/42. However, compared to control cells, adiponectin, an insulin sensitizer, was elevated in adipocytes treated with LSC. In addition, LSC treatment increased lipolysis by increasing pAMPK-α and suppressing FAS, ACC, and PPAR-γ expression, similarly to the effects of AICAR, an AMPK agonist. In conclusion, L. citreum is a novel probiotic strain that can be used to treat obesity and its associated metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Sunchon University, Suncheon 57922, Republic of Korea.
- Grassland and Forages Division, National Institute of Animal Science, Rural Development Administration, Cheonan 31000, Republic of Korea.
- Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.
- Animal Genomics and Bioinformatics Division, National Institute of Animal Science, Jeonju 55365, Republic of Korea.
ORCID-Profile: Ilavenil Soundharrajan, Ki-Choon Choi
Zitieren
APA
Han, H. S., Soundharrajan, I., Valan Arasu, M., Kim, D., & Choi, K. C. (2023). Leuconostoc Citreum Inhibits Adipogenesis and Lipogenesis by Inhibiting p38 MAPK/Erk 44/42 and Stimulating AMPKα Signaling Pathways. International Journal of Molecular Sciences, 24(8), 7367. https://doi.org/10.3390/ijms24087367
Vancouver
Han HS, Soundharrajan I, Valan Arasu M, Kim D, Choi KC. Leuconostoc Citreum Inhibits Adipogenesis and Lipogenesis by Inhibiting p38 MAPK/Erk 44/42 and Stimulating AMPKα Signaling Pathways. International Journal of Molecular Sciences. 2023;24(8):7367. doi:10.3390/ijms24087367
BibTeX
@article{Han2023,
author = {Han, Hyo-Shim and Soundharrajan, Ilavenil and Valan Arasu, Mariadhas and Kim, Dahye and Choi, Ki-Choon},
title = {Leuconostoc Citreum Inhibits Adipogenesis and Lipogenesis by Inhibiting p38 MAPK/Erk 44/42 and Stimulating AMPKα Signaling Pathways},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {8},
pages = {7367},
doi = {10.3390/ijms24087367}
}
EUVIMED